Department of Neuroscience, Medical University of South Carolina (MUSC), 410C Basic Sciences Building, 173 Ashley Avenue, Charleston, SC, 29425, USA.
Neurobiology of Addiction Research Center, Medical University of South Carolina, Charleston, SC, 29425, USA.
Mol Neurobiol. 2020 Jan;57(1):346-357. doi: 10.1007/s12035-019-01711-9. Epub 2019 Jul 29.
Cocaine addiction remains a major health concern with limited effective treatment options. A better understanding of mechanisms underlying relapse may help inform the development of new pharmacotherapies. Emerging evidence suggests that collapsin response mediator protein 2 (CRMP2) regulates presynaptic excitatory neurotransmission and contributes to pathological changes during diseases, such as neuropathic pain and substance use disorders. We examined the role of CRMP2 and its interactions with a known binding partner, CaV2.2, in cocaine-seeking behavior. We employed the rodent self-administration model of relapse to drug seeking and focused on the prefrontal cortex (PFC) for its well-established role in reinstatement behaviors. Our results indicated that repeated cocaine self-administration resulted in a dynamic and persistent alteration in the PFC expression of CRMP2 and its binding partner, the CaV2.2 (N-type) voltage-gated calcium channel. Following cocaine self-administration and extinction training, the expression of both CRMP2 and CaV2.2 was reduced relative to yoked saline controls. By contrast, cued reinstatement potentiated CRMP2 expression and increased CaV2.2 expression above extinction levels. Lastly, we utilized the recently developed peptide myr-TAT-CBD3 to disrupt the interaction between CRMP2 and CaV2.2 in vivo. We assessed the reinstatement behavior after infusing this peptide directly into the medial PFC and found that it decreased cue-induced reinstatement of cocaine seeking. Taken together, these data suggest that neuroadaptations in the CRMP2/CaV2.2 signaling cascade in the PFC can facilitate drug-seeking behavior. Targeting such interactions has implications for the treatment of cocaine relapse behavior.
可卡因成瘾仍然是一个主要的健康问题,有效的治疗选择有限。更好地了解复发的机制可能有助于为新的药物治疗提供信息。新出现的证据表明, collapsin 反应介质蛋白 2(CRMP2)调节突触前兴奋性神经传递,并有助于神经病理性疼痛和物质使用障碍等疾病中的病理变化。我们研究了 CRMP2 及其与已知结合伴侣 CaV2.2 的相互作用在可卡因寻求行为中的作用。我们采用了啮齿动物自我给药复发模型来研究药物寻求,并专注于前额叶皮层(PFC),因为它在重新激活行为中具有明确的作用。我们的结果表明,反复可卡因自我给药导致 PFC 中 CRMP2 及其结合伴侣 CaV2.2(N 型)电压门控钙通道的表达发生动态和持久改变。在可卡因自我给药和消退训练后,与配对盐水对照相比,CRMP2 和 CaV2.2 的表达均减少。相比之下,线索重新激活增强了 CRMP2 的表达,并使 CaV2.2 的表达高于消退水平。最后,我们利用最近开发的肽 myr-TAT-CBD3 在体内破坏 CRMP2 和 CaV2.2 之间的相互作用。我们评估了将这种肽直接注入内侧 PFC 后重新激活的行为,发现它减少了线索诱导的可卡因寻求重新激活。总之,这些数据表明,PFC 中 CRMP2/CaV2.2 信号级联的神经适应性可以促进药物寻求行为。针对这种相互作用可能对可卡因复发行为的治疗具有重要意义。